{"id":"https://openalex.org/W2390141573","doi":null,"title":"The Inhibitory Effect of Sorafenib Combined with Epirubicin on Proliferation in Breast Cancer MCF-7 Cells","display_name":"The Inhibitory Effect of Sorafenib Combined with Epirubicin on Proliferation in Breast Cancer MCF-7 Cells","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2390141573","mag":"2390141573"},"language":"en","primary_location":{"id":"mag:2390141573","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-XHON201107012.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764860634","display_name":"Journal of Chinese Oncology","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Chinese Oncology","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101956162","display_name":"Wu Bing","orcid":"https://orcid.org/0000-0002-8757-0457","observed_orcids":["https://orcid.org/0000-0002-8757-0457"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Wu Bing","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8757-0457","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5101956162"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.3199416,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7432000041007996,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7432000041007996,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.05810000002384186,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.026100000366568565,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":1.0},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6679999828338623},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8899999856948853},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":1.0},{"id":"https://openalex.org/keywords/cell-proliferation-inhibition","display_name":"cell proliferation inhibition","score":0.9380000233650208},{"id":"https://openalex.org/keywords/synergistic-effect","display_name":"synergistic effect","score":0.8270000219345093},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9288297295570374},{"id":"https://openalex.org/C109541995","wikidata":"https://www.wikidata.org/wiki/Q1881253","display_name":"MCF-7","level":5,"score":0.8675927519798279},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.8231542110443115},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7704222798347473},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5057621002197266},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4683470129966736},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40859222412109375},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.38368889689445496},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3732476234436035},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.35023319721221924},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3210272789001465},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.18749284744262695},{"id":"https://openalex.org/C2994423619","wikidata":"https://www.wikidata.org/wiki/Q9103","display_name":"Human breast","level":4,"score":0.16106635332107544},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14153194427490234},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13279908895492554}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2390141573","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-XHON201107012.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764860634","display_name":"Journal of Chinese Oncology","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Chinese Oncology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2372965651","https://openalex.org/W2390656650","https://openalex.org/W2106623623","https://openalex.org/W2369519808","https://openalex.org/W4395116444","https://openalex.org/W3083016562","https://openalex.org/W4200299807","https://openalex.org/W3020593266","https://openalex.org/W2341111379","https://openalex.org/W3048090144"],"abstract_inverted_index":{"[Purpose]":[0],"To":[1],"investigate":[2],"the":[3,13,61,70,76,84,104,123],"inhibitory":[4,36],"effect":[5,37,114,134],"of":[6,24,38,64,93,106,115,125],"sorafenib":[7],"combined":[8],"with":[9],"epirubicin":[10],"(EPI)":[11],"on":[12,30,43,90],"proliferation":[14,45,105,124],"in":[15,46,135],"breast":[16],"cancer":[17],"MCF-7":[18,25,44,65,94,107,126,137],"cells.":[19,127],"[Methods]":[20],"The":[21,35,56,87],"growth":[22,57,62],"curve":[23,58],"cells":[26,66,95,108,138],"and":[27,40,99,119,129],"cloning":[28,88],"efficiency":[29,89],"14th":[31,91],"day":[32,92],"was":[33,48,67,96],"detected.":[34],"sorafenib,EPI":[39],"sorafenib+EPI":[41],"treatment":[42],"vitro":[47],"assessed":[49],"by":[50],"MTT":[51],"assay":[52],"at":[53,69,80,109],"72h.":[54],"[Results]":[55],"showed":[59],"that":[60],"velocity":[63],"fast":[68],"1st~4th":[71],"day,but":[72],"slowed":[73],"down":[74],"after":[75,83],"4th":[77],"day,and":[78],"stayed":[79],"a":[81,112,132],"standstill":[82],"10th":[85],"day.":[86],"37.2%.":[97],"Sorafenib":[98,118,128],"EPI":[100,120,130],"both":[101],"significantly":[102],"inhibited":[103],"72h,":[110],"showing":[111],"synergistic":[113,133],"combination.":[116],"[Conclusion]":[117],"can":[121],"inhibite":[122],"play":[131],"inhibiting":[136],"proliferation.":[139]},"counts_by_year":[],"updated_date":"2025-10-10T17:16:08.811792","created_date":"2016-06-24T00:00:00"}